- Announced it received two 510(k) clearances from the US FDA to market both the Company's proprietary Version 2.0 Tactile Guidance System (TGS), branded as the MAKO RIO, and its bicompartmental knee resurfacing implant system, branded as RESTORIS MCK.
- MAKO currently expects to commercially launch both the RIO system and the RESTORIS MCK system in the first half of 2009.

Other headlines for [MAKO]

• MAKO 12/30/1899 00:00am
  MAKO Surgical Receives FDA Clearance to Market Both Its Version 2.0 Tactile Guidance System and Its Bicompartmental Knee Resurfacing Implant System- Announced it received two 510(k) clearances from the US FDA to more...
  
• MAKO 12/30/1899 00:00am
  MAKO Surgical Registers 13M shares for holders (52.2% of shares outstanding)
  

Healthcare sector headlines

• ROG.SZ Today 06:02am
  Roche Holding AG Plexxikon Enters Second Partnership with Co. To Develop PLX5568 For Polycystic Kidney Disease- The main focus of this partnership will be the development of this small molecule inhibitor of Raf more...
  
• TOPO.DC Today 04:03am
  Topotarget Initiates phase 2 portion of a NCI sponsored study with belinostat given at higher than usual doses for liver cancer- Belinostat can be safely administered in higher doses - Co. begins phase 2 in more...
  
• QMED.SW Today 02:11am
  Q-Med Terminates international distribution agreement with Palomar- Agreement was originally entered back in Jan 2008 - Due to the downturn in the world-wide economic environment, Q-Med''s efforts are more...
  
• AKR.UK Today 02:07am
  Akers Biosciences, Inc. Reaffirms pretax profit in line with prior guidance, expects to report positive net profit- The second half of the year was significantly more profitable than the first, owing largely to the sale of more...
  
• IDMI Today 01:59am
  IDM Pharma Inc Update on Mifamurtide European Regulatory Status